WHC is still in active development. Read this to understand our approach.
depiction of UEQUQVLFIPOEMF-UHFFFAOYSA-N.svg
isomerdesign

Mianserin

Verificar en isomerdesign

pubchem

Mianserin

Verificar en pubchem

drugmap

Mianserin

Verificar en drugmap

wiki

Mianserin

Verificar en wiki

Data

InChI: InChI=1S/C18H20N2/c1-19-10-11-20-17-9-5-3-7-15(17)12-14-6-2-4-8-16(14)18(20)13-19/h2-9,18H,10-13H2,1H3

Sinónimos: KBioGR_001820,1,2,3,4,10,14b-Hexahydro-2-methyldibenzo[c,f]pyrazino[1,2-a]azepine,Spectrum4_001260, Mianserin (INN),Spectrum_001810,Prestwick3_000099,5-methyl-2,5-diazatetracyclo[13.4.0.02,7.08,13]nonadeca-1(19),8,10,12,15,17-hexaene,Dibenzo[c,f]pyrazino[1,2-a]azepine, 1,2,3,4,10,14b-hexahydro-2-methyl-,BRD-A19661776-001-01-5, 2-Methyl-1,2,3,4,10,14b-hexahydrodibenzo[c,f]pyrazino[1,2-a]azepine,SPBio_001997, Tolvin (TN),NCGC00015656-23,KBio2_004869, Mianserinum [INN-Latin],Tox21_110191_1, Mianserina [INN-Spanish],(+-)-Athymil,FT-0697022,NCGC00015656-10,D08216,Mianserin (INN),Dibenzo(c,f)pyrazino(1,2-a)azepine, 1,2,3,4,10,14b-hexahydro-2-methyl-,AKOS005216268,HY-B0188, Tolvan,1,2,3,4,10,14b-hexahydro-2-methyldibenzo[c,f]pyrazino[1,2-a]azepine,Mianserina, Mianserine [INN-French],PDSP1_001532,HMS2089A04,L000736,mianserin a, Mianseryna,2-Methyl-1,2,3,4,10,14b-hexahydrodibenzo[c,f]pyrazino[1,2-a]azepine,Mianserin [INN:BAN],Biomol-NT_000135,24219-97-4,CHEBI:51137,SCHEMBL18020,Depnon,DTXSID6023317,BPBio1_000064,NCGC00015656-05,CCG-204829, Mianserine,Prestwick1_000099,EINECS 246-088-6,5-methyl-2,5-diazatetracyclo[13.4.0.0^{2,7}.0^{8,13}]nonadeca-1(15),8(13),9,11,16,18-hexaene, Mianseryna [Polish],NCGC00015656-04,BRN 0755346,mianserin, Norval (TN),NCGC00015656-09, Mianserin [INN:BAN],Q416701,5-methyl-2,5-diazatetracyclo[13.4.0.0^{2,7}.0^{8,13}]nonadeca-1(19),8,10,12,15,17-hexaene,Prestwick0_000099,KBio3_003016,Mianserine,Mianserinum [INN-Latin],Tox21_110191, Mianserin Monohydrochloride,Mianserin,Lantanon,MIANSERIN [MI],Tolvon (TN),NCGC00024926-04,DSSTox_GSID_23317,MIANSERIN [HSDB], Tolvon (TN),1,2,3,4,10,14b-Hexahydro-2-methyldibenzo(c,f)pyrazino(1,2-a)azepine,NINDS_000844,SBI-0050722.P003, Norval,Spectrum5_001772,NCGC00015656-12,EN300-18559884,BRD-A19661776-003-05-2, 1,2,3,4,10,14b-Hexahydro-2-methyldibenzo(c,f)pyrazino(1,2-a)azepine, Bolvidon (TN),MIANSERIN [INN],DSSTox_CID_3317,1,2,3,4,10,14B-HEXAHYDRO-2-METHYLDIBENZO(C,F)-PYRAZINO(1,2-A)AZEPINE,2-Methyl-1,2,3,4,10,14b-hexahydrodibenzo[c,f]pyrazino[1,2-a]azepine #,IDI1_000844,Norval,Prestwick2_000099,Spectrum3_001836,KBio2_002301,GTPL135,KBio2_007437,Oprea1_703627,CS-2078,HSDB 7182,AC-631,Tolvon,DSSTox_RID_76974,Mianseryna,PDSP2_001516,AM20041174,Mianseryna [Polish],Mianserinum,J16.389I,Mianserina [INN-Spanish],Lerivon,BPBio1_000331,BSPBio_000058,KBio1_000844,SDCCGSBI-0050722.P004,DivK1c_000844,BSPBio_003511,KBioSS_002303,DB06148,Mianserine [INN-French],NCGC00024926-03,Spectrum2_001203,MIANSERIN [VANDF],BDBM50222218,(+/-)-Mianserin,Lopac0_000744,NCGC00015656-08,MIANSERIN [WHO-DD],BRD-A19661776-003-16-9,CHEMBL6437,SPBio_000986,NCGC00015656-06, Mianserinum,UNII-250PJI13LM, Tolvon,250PJI13LM,CAS-24219-97-4

Estimated data

Solubilidad: -2.928 (log(S) in mol/L prediction using SolTranNet)

Blood Brain Barrier Permeability: Yes (prediction using frontiersin.org)

Addictivity Prediction: 42.6% (prediction based on www.mdpi.com)

Similitudes

The following is a set of comparisons to understand the properties of this compound. This is still higly experimental and is still under active development. Please refer to our series of blog posts to fully understand our approach and its limitations. This information is for informational purposes only and should not be construed as medical advice.